These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37899392)

  • 1. Psychedelics action and schizophrenia.
    Maćkowiak M
    Pharmacol Rep; 2023 Dec; 75(6):1350-1361. PubMed ID: 37899392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation.
    Wolf G; Singh S; Blakolmer K; Lerer L; Lifschytz T; Heresco-Levy U; Lotan A; Lerer B
    Mol Psychiatry; 2023 Jan; 28(1):44-58. PubMed ID: 36280752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelics and schizophrenia.
    González-Maeso J; Sealfon SC
    Trends Neurosci; 2009 Apr; 32(4):225-32. PubMed ID: 19269047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the 5-HT
    Cameron LP; Benetatos J; Lewis V; Bonniwell EM; Jaster AM; Moliner R; Castrén E; McCorvy JD; Palner M; Aguilar-Valles A
    J Neurosci; 2023 Nov; 43(45):7472-7482. PubMed ID: 37940583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets of psychedelic-induced plasticity.
    Jaster AM; de la Fuente Revenga M; González-Maeso J
    J Neurochem; 2022 Jul; 162(1):80-88. PubMed ID: 34741320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
    Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE
    ACS Chem Neurosci; 2023 Feb; 14(3):351-358. PubMed ID: 36630260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review.
    DiVito AJ; Leger RF
    Mol Biol Rep; 2020 Dec; 47(12):9791-9799. PubMed ID: 33231817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT
    Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal Behavior in Psychedelic Research.
    Odland AU; Kristensen JL; Andreasen JT
    Pharmacol Rev; 2022 Oct; 74(4):1176-1205. PubMed ID: 36180111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.
    de la Fuente Revenga M; Zhu B; Guevara CA; Naler LB; Saunders JM; Zhou Z; Toneatti R; Sierra S; Wolstenholme JT; Beardsley PM; Huntley GW; Lu C; González-Maeso J
    Cell Rep; 2021 Oct; 37(3):109836. PubMed ID: 34686347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Paradigms of Old Psychedelics in Schizophrenia.
    Mahmood D; Alenezi SK; Anwar MJ; Azam F; Qureshi KA; Jaremko M
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 2A Receptor (5-HT
    Duan W; Cao D; Wang S; Cheng J
    Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry and Structure-Activity Relationships of Psychedelics.
    Nichols DE
    Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of serotonergic psychedelics.
    Hanks JB; González-Maeso J
    ACS Chem Neurosci; 2013 Jan; 4(1):33-42. PubMed ID: 23336043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers.
    Maia JM; de Oliveira BSA; Branco LGS; Soriano RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr; 131():110951. PubMed ID: 38307161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies.
    Fissler P; Vandersmissen A; Filippi M; Mavioglu RN; Scholkmann F; Karabatsiakis A; Krähenmann R
    J Psychopharmacol; 2023 Jul; 37(7):679-686. PubMed ID: 37122193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.
    Olson DE
    Biochemistry; 2022 Feb; 61(3):127-136. PubMed ID: 35060714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.